Aigen Investment Management, LP Laboratory Corp Of America Holdings Transaction History

Aigen Investment Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$201.05 - $221.7 $19,702 - $21,726	-98 Reduced 4.06%	2,315 $465,000
Q2 2023 Aug 14, 2023	BUY	$211.93 - $241.33 $511,387 - $582,329	2,413 New	2,413 $582,000
Q2 2022 Aug 02, 2022	SELL	$213.86 - $277.87 $2.56 Million - $3.32 Million	-11,948 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$259.82 - $298.18 $2.22 Million - $2.54 Million	8,531 Added 249.66%	11,948 $3.15 Million
Q4 2021 Feb 11, 2022	BUY	$271.6 - $314.21 $928,057 - $1.07 Million	3,417 New	3,417 $1.02 Million
Q2 2020 Aug 10, 2020	SELL	$113.31 - $182.44 $388,086 - $624,857	-3,425 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$104.32 - $195.28 $302,840 - $566,897	-2,903 Reduced 45.88%	3,425 $433,000
Q4 2019 Feb 04, 2020	BUY	$163.48 - $173.61 $1.03 Million - $1.1 Million	6,328 New	6,328 $1.07 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.